Ascend Wellness (OTC:AAWH) Rating Reiterated by Needham & Company LLC

Ascend Wellness (OTC:AAWH – Get Rating)‘s stock had its “buy” rating reiterated by analysts at Needham & Company LLC in a research note issued on Wednesday, Benzinga reports. They currently have a $2.75 target price on the stock. Needham & Company LLC’s target price would indicate a potential upside of 141.23% from the company’s previous close.

Separately, Cantor Fitzgerald assumed coverage on shares of Ascend Wellness in a report on Friday, February 10th. They issued a “neutral” rating for the company.

Ascend Wellness Trading Down 0.9 %

Shares of AAWH stock opened at $1.14 on Wednesday. The business has a 50-day moving average of $1.30 and a 200 day moving average of $1.66. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.59 and a quick ratio of 0.92. Ascend Wellness has a 1-year low of $0.98 and a 1-year high of $4.23. The stock has a market capitalization of $214.99 million, a PE ratio of -2.59 and a beta of 2.79.

About Ascend Wellness

(Get Rating)

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. Its cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. As of December 31, 2021, the company operated 20 retail locations.